Search Results 61-70 of 17025 for Ulcerative%2Bcolitis

  1. Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis - Mayo Clinic

    The purpose of this study is to determine whether RPC1063 is effective in the treatment of Ulcerative Colitis (UC). Participation eligibility. Participant ...

  2. Balsalazide (Oral Route) Description and Brand Names - Mayo Clinic

    Balsalazide is used to treat an inflammatory bowel disease called ulcerative colitis. Balsalazide capsules are used to treat mild to moderately active ...

  3. Research establishes strong association between family history and increased risk of colorectal cancer in patients with inflammatory bowel diseases - Mayo Clinic

    ... colitis, 5,084 (53.5%) were diagnosed with ... ulcerative colitis, with or without concurrent ... IBD are at greater risk of developing CRC than are females with ...

  4. The role of capsule endoscopy in diagnosis and management of inflammatory bowel disease - Mayo Clinic

    While small bowel CE has been fairly well studied in CD , colon capsule endoscopy (CCE) for ulcerative colitis (UC) has not been as well studied. Therefore ...

  5. TD-1473 for Active Ulcerative Colitis (UC) - Mayo Clinic

    This exploratory study will also serve as a signal seeking endeavor to demonstrate biologic effect associated with TD-1473 through biomarker analysis and ...

  6. Crohn's disease - Diagnosis and treatment - Mayo Clinic

    Look for information from the Crohn's & Colitis Foundation. Join a support group. Although support groups aren't for everyone, they can provide valuable ...

  7. Scott Hennen on Ulcerative Colitis and Mayo Clinic

    ... ulcerative colitis, which was first diagnosed in 1997. Scott had previously described his reasons for being public about his medical condition in this post ...

  8. Long-Term Safety of PF-00547659 in Ulcerative Colitis - Mayo Clinic

    Subjects with Ulcerative Colitis who have completed an induction study with PF-00547659 will receive an additional 72 weeks of open-label treatment to ...

  9. Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis - Mayo Clinic

    ... ulcerative colitis (UC). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or ...

  10. A Study of Vedolizumab in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) - Mayo Clinic

    The purpose of this study is to determine the long-term safety of vedolizumab intravenous (IV) treatment in pediatric participants with Ulcerative Colitis (UC) ...